Drug Profile
Meningococcal vaccine groups A and C conjugate - Aventis Pasteur
Latest Information Update: 06 Apr 2022
Price :
$50
*
At a glance
- Originator sanofi pasteur
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Meningococcal group A infections; Meningococcal group C infections
Most Recent Events
- 03 Feb 2022 Sanofi Pasteur has been rebranded under Sanofi
- 24 Dec 1999 Pasteur Mérieux Connaught is now a subsidiary of Aventis and its new name is Aventis Pasteur
- 05 Oct 1999 New profile